IL29810A0 - Ergot peptide alkaloid compounds - Google Patents
Ergot peptide alkaloid compoundsInfo
- Publication number
- IL29810A0 IL29810A0 IL6829810A IL2981068A IL29810A0 IL 29810 A0 IL29810 A0 IL 29810A0 IL 6829810 A IL6829810 A IL 6829810A IL 2981068 A IL2981068 A IL 2981068A IL 29810 A0 IL29810 A0 IL 29810A0
- Authority
- IL
- Israel
- Prior art keywords
- alkaloid compounds
- ergot peptide
- peptide alkaloid
- ergot
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH523667A CH503031A (en) | 1967-04-12 | 1967-04-12 | Process for the preparation of heterocyclic compounds |
CH1648467 | 1967-11-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL29810A0 true IL29810A0 (en) | 1968-06-20 |
IL29810A IL29810A (en) | 1971-08-25 |
Family
ID=25697273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL29810A IL29810A (en) | 1967-04-12 | 1968-04-11 | Ergot alkaloid compounds |
Country Status (15)
Country | Link |
---|---|
US (1) | US3586683A (en) |
AT (1) | AT307628B (en) |
BE (1) | BE713489A (en) |
CS (1) | CS149617B2 (en) |
DE (1) | DE1770161A1 (en) |
DK (1) | DK123034B (en) |
ES (1) | ES352623A1 (en) |
FR (2) | FR1583797A (en) |
GB (1) | GB1216135A (en) |
IL (1) | IL29810A (en) |
NL (1) | NL6804806A (en) |
NO (1) | NO124311B (en) |
OA (1) | OA03635A (en) |
PL (1) | PL79309B1 (en) |
SE (1) | SE335740B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH508628A (en) * | 1968-06-25 | 1971-06-15 | Sandoz Ag | Process for the preparation of new heterocyclic compounds |
CH517099A (en) * | 1969-06-20 | 1971-12-31 | Sandoz Ag | Process for the production of new ergot peptide alkaloids |
CA990287A (en) * | 1972-09-26 | 1976-06-01 | Sandoz Patents Limited | 13-bromo-lysergic acid compounds |
DK140017B (en) * | 1973-07-09 | 1979-06-05 | Sandoz Ag | Process for the preparation of octahydro-oxazolo (3,2-a) pyrrolo (2,1-c) pyrazine derivatives. |
CH601321A5 (en) * | 1975-01-06 | 1978-07-14 | Sandoz Ag | |
DE2962303D1 (en) * | 1978-01-20 | 1982-04-29 | Sandoz Ag | Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them |
DE3116257A1 (en) * | 1980-05-30 | 1982-01-07 | GAO Gesellschaft für Automation und Organisation mbH, 8000 München | Security paper with authentication features |
US4694103A (en) * | 1986-05-19 | 1987-09-15 | Minnesota Mining And Manufacturing Company | Method of preparing N-acryloyl-α-amino acids |
US7202279B1 (en) * | 1998-02-11 | 2007-04-10 | Georgetown University | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
WO2011079313A1 (en) * | 2009-12-23 | 2011-06-30 | Map Pharmaceuticals, Inc. | Novel ergoline analogs |
KR20140042868A (en) | 2011-06-23 | 2014-04-07 | 맵 파마슈티컬스, 인코포레이티드 | Novel fluoroergoline analogs |
EP2793580A4 (en) | 2011-12-19 | 2015-05-20 | Map Pharmaceuticals Inc | Novel iso-ergoline derivatives |
US8946420B2 (en) | 2011-12-21 | 2015-02-03 | Map Pharmaceuticals, Inc. | Neuromodulatory compounds |
US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
CN111333560B (en) * | 2020-04-13 | 2024-01-23 | 合肥工业大学 | Method for preparing spiro beta-lactam |
-
1968
- 1968-03-29 FR FR1583797D patent/FR1583797A/fr not_active Expired
- 1968-04-05 NL NL6804806A patent/NL6804806A/xx unknown
- 1968-04-05 DK DK155168AA patent/DK123034B/en unknown
- 1968-04-05 SE SE04609/68A patent/SE335740B/xx unknown
- 1968-04-08 NO NO1373/68A patent/NO124311B/no unknown
- 1968-04-08 US US719674A patent/US3586683A/en not_active Expired - Lifetime
- 1968-04-09 CS CS2622A patent/CS149617B2/cs unknown
- 1968-04-09 DE DE19681770161 patent/DE1770161A1/en active Pending
- 1968-04-10 AT AT355968A patent/AT307628B/en not_active IP Right Cessation
- 1968-04-10 BE BE713489D patent/BE713489A/xx unknown
- 1968-04-10 ES ES352623A patent/ES352623A1/en not_active Expired
- 1968-04-11 IL IL29810A patent/IL29810A/en unknown
- 1968-04-11 GB GB07560/68A patent/GB1216135A/en not_active Expired
- 1968-04-12 PL PL1968126424A patent/PL79309B1/pl unknown
- 1968-06-28 FR FR157097A patent/FR7902M/fr not_active Expired
-
1969
- 1969-04-11 OA OA53254A patent/OA03635A/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB1216135A (en) | 1970-12-16 |
OA03635A (en) | 1971-12-24 |
FR7902M (en) | 1970-05-11 |
IL29810A (en) | 1971-08-25 |
US3586683A (en) | 1971-06-22 |
NO124311B (en) | 1972-04-04 |
DK123034B (en) | 1972-05-08 |
NL6804806A (en) | 1968-10-14 |
SE335740B (en) | 1971-06-07 |
ES352623A1 (en) | 1970-01-01 |
FR1583797A (en) | 1969-12-05 |
AT307628B (en) | 1973-05-25 |
PL79309B1 (en) | 1975-06-30 |
DE1770161A1 (en) | 1971-10-14 |
CS149617B2 (en) | 1973-07-25 |
BE713489A (en) | 1968-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY620A (en) | Substituted-5-pyrimidine compounds | |
IL29810A0 (en) | Ergot peptide alkaloid compounds | |
CA952107A (en) | Ergot peptide alkaloids | |
IL30703A0 (en) | Penicillin preparation | |
MY7400278A (en) | 4-phenyl-quinalozinone derivative | |
IL30053A (en) | Process for the preparation of rifamycins | |
IL29732A0 (en) | 2-substituted quinolizinium compounds | |
IL31187A0 (en) | New adamantylene compounds | |
IL30235A0 (en) | New ergoline derivatives | |
IE32820B1 (en) | 11beta-methyl-19-norpregnene compounds | |
CA764443A (en) | Synthetic alkaloids | |
CA751909A (en) | Alkaloids | |
CA29089S (en) | Tartan | |
IE31583L (en) | Imidazolidinone derivative | |
IE31743L (en) | Glycine derivatives | |
AU426257B2 (en) | Ergoline derivatives | |
IE31153L (en) | Quinoline derivatives | |
IE31305L (en) | Quinoline derivatives | |
IL27993A (en) | Nitrofuryl quinoline derivatives | |
IE31458L (en) | Quinoline derivatives | |
IE32255L (en) | Substituted -5- pyrimidine compounds | |
IL30874A0 (en) | Substituted hydroxyethylglycine compounds | |
MY6700108A (en) | Benzodiazepine compounds | |
IE31554L (en) | Nitro-furyl quinoline derivative | |
AU3987068A (en) | Ergoline derivatives |